Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension.
Baptiste GouyouKatja GrünAnne KerschenmeyerAlessandra VillaMattia MatasciAndrea SchrepperAlexander PfeilLaura BäzChristian JungP Christian SchulzeDario NeriMarcus FranzPublished in: International journal of molecular sciences (2021)
Our study provides first pre-clinical evidence for the use of F8IL9F8 as a new therapeutic agent for PH in terms of a disease-modifying concept addressing cardiovascular remodeling.